Trials / Completed
CompletedNCT03912688
TEAS Reduces Remifentanil Consumption
Effect of Transcutaneous Electrical Acupoint Stimulation on Remifentanil Consumption and Postoperative Pain in Patients Undergoing Radical Mastectomy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 153 (actual)
- Sponsor
- Air Force Military Medical University, China · Academic / Other
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Transcutaneous electrical acupoint stimulation (TEAS) has been shown to decrease the need of opioids including remifentanil during anaesthesia. However, it is not clear whether combination of two or more acupoints could induce stronger analgesia. Moreover, evidence for the long-term effect of TEAS has been limited. The present study was to compare the short-term and long-term effect on pain of dual-acupoint and single-acupoint TEAS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | acupoint stimulation | |
| DEVICE | single acupoint | |
| DEVICE | dual acupoints |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2019-04-11
- Last updated
- 2019-04-11
Source: ClinicalTrials.gov record NCT03912688. Inclusion in this directory is not an endorsement.